Takuya Miyagawa Selected Research

Takuya Miyagawa Research Topics

Disease

12	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 10/2017
7	Melanoma (Melanoma, Malignant) 01/2023 - 01/2017
6	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 01/2018
5	Neoplasms (Cancer) 01/2024 - 02/2020
3	Inflammation (Inflammations) 01/2022 - 09/2020
3	Fibrosis (Cirrhosis) 01/2022 - 01/2021
3	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2015
3	Telangiectasis (Telangiectasia) 08/2021 - 01/2018
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 02/2018
2	Corneal Neovascularization 04/2020 - 01/2017
2	Pulmonary Arterial Hypertension 01/2020 - 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2024
1	Carcinogenesis 01/2024
1	Triple Negative Breast Neoplasms 01/2024
1	Pyelonephritis 05/2023
1	Hydronephrosis 05/2023
1	Enteritis 05/2023
1	Cystitis 05/2023
1	Fistula 02/2023
1	Basal Cell Carcinoma (Rodent Ulcer) 09/2022
1	Extramammary Paget Disease (Paget Disease, Extramammary) 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Arteritis 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Vascular Diseases (Vascular Disease) 01/2022
1	Mycosis Fungoides 01/2022
1	Joint Diseases (Joint Disease) 02/2021
1	Sclerosis 01/2021
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2021
1	Localized Scleroderma (Morphea) 11/2018
1	Contracture 02/2018
1	digital ulcers 01/2018
1	Cicatrix (Scar) 01/2018
1	Vitiligo 12/2017

Drug/Important Bio-Agent (IBA)

3	NivolumabIBA 01/2023 - 12/2017
3	ChemokinesIBA 01/2022 - 01/2018
2	IpilimumabIBA 01/2023 - 01/2023
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 01/2021
2	AntigensIBA 01/2022 - 02/2018
2	CytokinesIBA 01/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2021 - 02/2020
2	Peptide Hydrolases (Proteases)FDA Link 09/2020 - 10/2019
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2019 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 11/2018 - 10/2017
1	microtubule-associated protein 1B (MAP5)IBA 01/2024
1	Proteins (Proteins, Gene)FDA Link 05/2023
1	Coloring Agents (Dyes)IBA 02/2023
1	Methylene Blue (Methylthioninium Chloride)FDA Link 02/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	5-((glucopyranosyloxy)methyl)uracilIBA 09/2022
1	CaspasesIBA 01/2022
1	Keratin-18 (Keratin 18)IBA 01/2022
1	squamous cell carcinoma-related antigenIBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	AutoantibodiesIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 08/2021
1	LigandsIBA 05/2021
1	Chemokine CXCL12IBA 02/2021
1	CollagenIBA 02/2021
1	S100A12 ProteinIBA 01/2021
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2021
1	Aldehyde Dehydrogenase 1 FamilyIBA 01/2021
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2021
1	cathepsin SIBA 09/2020
1	Hyaluronic Acid (Hyaluronan)IBA 04/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2020
1	gallocatechol (epigallocatechin)IBA 04/2020
1	arginyl-glycyl-aspartic acidIBA 04/2020
1	GelatinIBA 04/2020
1	Complement Factor D (Factor D)IBA 01/2020
1	Metalloproteases (Metalloproteinases)IBA 10/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2018
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 11/2018
1	ProgranulinsIBA 11/2018
1	Protein Isoforms (Isoforms)IBA 05/2018
1	lysophosphatidylserineIBA 05/2018
1	EnzymesIBA 05/2018
1	LysophospholipidsIBA 05/2018
1	PhosphatidylserinesIBA 05/2018
1	Phospholipases A1 (Phospholipase A1)IBA 05/2018
1	Heparin (Liquaemin)FDA LinkGeneric 02/2018
1	Epidermal Growth Factor (EGF)IBA 02/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2018
1	CarbohydratesIBA 02/2018
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 02/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	Gemcitabine FDA Link 03/2017
1	Ifosfamide FDA LinkGeneric 03/2017

Therapy/Procedure

8	Therapeutics 01/2023 - 06/2011
2	Radiotherapy 05/2023 - 08/2015
2	Immunotherapy 01/2023 - 01/2017
2	Drug Therapy (Chemotherapy) 03/2017 - 08/2015
1	Operative Surgical Procedures 02/2020
1	Phototherapy (Light Therapy) 12/2017